Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab after lumbar fusion for lumbar spinal stenosis with osteoporosis
ChiCTR2100053054Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital
- Start
- Nov 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of denosumab in osteoporosis and lumbar spinal stenosis (LSS) (2 arms), sponsored by The First Affiliated Hospital. Primary endpoints: Osteocalcin, Procollagen type 1 N-terminal propeptide and 5 more. Started Nov 2021; status: recruiting.
02
Drugs
denosumab
03
Conditions
osteoporosislumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on ChiCTR2100053054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053054.